Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.11B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$317M |
| 3 |
Linde
LIN
|
+$290M |
| 4 |
Danaher
DHR
|
+$275M |
| 5 |
Home Depot
HD
|
+$246M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$732M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$731M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$574M |
| 4 |
Meta Platforms (Facebook)
META
|
+$573M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$484M |
Sector Composition
| 1 | Financials | 16.4% |
| 2 | Technology | 14.23% |
| 3 | Healthcare | 12.49% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3551
FVCBankcorp
FVCB
$243M
| $176K | ﹤0.01% |
+16,607
| New | +$176K |
|
3552
Verrica Pharmaceuticals
VRCA
$46.4M
| $175K | ﹤0.01% |
+39,565
| New | +$175K |
|
3553
Tenax Therapeutics
TENX
$27.5M
| $174K | ﹤0.01% |
26,626
-183
| -0.7% | -$1.2K |
|
3554
Valhi
VHI
$460M
| $174K | ﹤0.01% |
10,729
+2,037
| +23% | +$33.1K |
|
3555
BlackRock CA Municipal Income Trust
BFZ
$329M
| $171K | ﹤0.01% |
15,567
| – | – |
|
3556
Complete Solaria, Inc. Common Stock
SPWR
$127M
| $170K | ﹤0.01% |
109,707
+82,210
| +299% | +$127K |
|
3557
KLX Energy Services
KLXE
$32.3M
| $170K | ﹤0.01% |
48,434
-76,866
| -61% | -$269K |
|
3558
PMV Pharmaceuticals
PMVP
$72.6M
| $169K | ﹤0.01% |
155,389
-162,631
| -51% | -$177K |
|
3559
ARKO Corp
ARKO
$567M
| $168K | ﹤0.01% |
+42,452
| New | +$168K |
|
3560
EyePoint Pharmaceuticals
EYPT
$917M
| $167K | ﹤0.01% |
30,800
-415,399
| -93% | -$2.25M |
|
|
SOHU
3561
Sohu.com
SOHU
$480M
| $165K | ﹤0.01% |
12,506
-32,115
| -72% | -$423K |
|
3562
Star Group
SGU
$393M
| $162K | ﹤0.01% |
12,281
-16,925
| -58% | -$223K |
|
|
BWAY
3563
Brainsway
BWAY
$301M
| $159K | ﹤0.01% |
16,812
+1,446
| +9% | +$13.7K |
|
3564
Upland Software
UPLD
$69.9M
| $158K | ﹤0.01% |
55,141
-51,223
| -48% | -$146K |
|
|
AKYA
3565
DELISTED
Akoya BioSciences
AKYA
| $157K | ﹤0.01% |
+113,245
| New | +$157K |
|
3566
DHT Holdings
DHT
$2.01B
| $156K | ﹤0.01% |
14,810
-54,697
| -79% | -$574K |
|
3567
Kezar Life Sciences
KZR
$28.9M
| $153K | ﹤0.01% |
31,380
-11,957
| -28% | -$58.4K |
|
3568
Bridger Aerospace
BAER
$107M
| $151K | ﹤0.01% |
133,562
+68,658
| +106% | +$77.6K |
|
3569
Clarus
CLAR
$149M
| $150K | ﹤0.01% |
39,875
-23,238
| -37% | -$87.1K |
|
3570
Repare Therapeutics
RPTX
$75.2M
| $149K | ﹤0.01% |
151,236
-19,723
| -12% | -$19.4K |
|
3571
Rallybio
RLYB
$25M
| $149K | ﹤0.01% |
227,230
-111,679
| -33% | -$73.1K |
|
3572
Traeger
COOK
$178M
| $148K | ﹤0.01% |
87,883
-319,382
| -78% | -$537K |
|
3573
OFS Capital
OFS
$117M
| $148K | ﹤0.01% |
+15,880
| New | +$148K |
|
3574
Arq
ARQ
$297M
| $147K | ﹤0.01% |
35,210
-118,260
| -77% | -$493K |
|
|
HIT
3575
Health In Tech, Inc. Class A Common Stock
HIT
$154M
| $147K | ﹤0.01% |
+221,730
| New | +$147K |
|